Initiate fourth cohort evaluating high-dose AMT-130
Delivered after the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 29 Jul 2025
- Due
- 30 Sep 2025
- Delivered
- October 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Q3 2025: Initiate a fourth cohort evaluating high-dose AMT-130 in six patients”
What we found
Evidence strength A What the grades mean
The company initiated the fourth cohort in October 2025, which occurred after the Q3 2025 deadline (September 30, 2025).
-
A uniQure N.V. 10-Q filed 2025-11-10
“In October 2025, we initiated and fully recruited a fourth cohort evaluating high-dose AMT-130 in six patients” ✓ confirmed on the page
Market reaction: the shares moved +6.5% against the S&P 500 over the three sessions around the disclosure (7 Nov 2025 to 12 Nov 2025). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Product other
- Indicative materiality
- Low rules
- Action
- Initiate
- Deliverable
- fourth cohort for AMT-130
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you uniQure N.V.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-QURE-001918 · Corrections policy